Catalyst Wire Dossier Catalyst Wire Dossier

3K3A-APC

3K3A-activated protein C · ZZ Biotech, LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for 3K3A-APC, covering 2014-04-10 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke [Phase 3]

See pricing